# Comparison of Two Liraglutide Formulations in Healthy Subjects

> **NCT01515579** · PHASE1 · COMPLETED · sponsor: **Novo Nordisk A/S** · enrollment: 22 (actual)

## Conditions studied

- Diabetes
- Healthy

## Interventions

- **DRUG:** liraglutide
- **DRUG:** liraglutide

## Key facts

- **NCT ID:** NCT01515579
- **Lead sponsor:** Novo Nordisk A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-04
- **Primary completion:** 2006-06
- **Final completion:** 2006-06
- **Target enrollment:** 22 (ACTUAL)
- **Last updated:** 2015-01-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01515579

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01515579, "Comparison of Two Liraglutide Formulations in Healthy Subjects". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01515579. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*